- Blog Featured Highlights PressITI's Michael Connolly, Manager of Process Development, presents a poster titled, "Functional evaluation of isoforms present in pDNA vaccines" at Aldevron's corporate offices located in Fargo, North Dakota A detailed abstractRead more
American Association for Cancer Research Annual Meeting, Mar. 29-Apr. 3, 2019, Atlanta, GA
Events Past EventsThe AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—andRead more2019 BIO CEO Investor Conference, Feb. 11-12, NYC
Events Past EventsThe BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is toRead more2019 Immuno-Oncology 360, Feb. 6-8, NYC
Events Past EventsReporting on Rapid Advancements of Clinical, Scientific and Business Developments in IO Immuno-Oncology 360° addresses business aspects, clinical advancements and scientific data for cancer immunotherapy that helps advance technology platformsRead more2019 J.P. Morgan Health Care Investor Conference, Jan. 6-10, San Francisco
Events Past Events2019 J.P. Morgan Health Care Investor Conference January 6 - 10, 2019 The Annual J.P. Morgan Healthcare Conference will take place January 6-10, 2019. This event continues to be one ofRead more2019 SITC ASCO Clinical Immuno Oncology Symposium Feb. 28-Mar. 2, San Francisco
Events Past EventsThe ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care. https://immunosym.org/Read more- Press Press ReleasesImmunomic Therapeutics Senior Director of Corporate Development to Present at Precision Lung Cancer World R&D Summit Discussion of lysosomal targeting technology as applied in cancer immunotherapy October 26, 2018 07:30Read more
Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference
Press Press ReleasesImmunomic Therapeutics CEO to Present at NYC Oncology Investor Conference To Discuss UNITE Technology Application in Oncology October 23, 2018 07:00 AM Eastern Daylight Time NEW YORK--(BUSINESS WIRE)--Immunomic Therapeutics,Read moreImmunomic Therapeutics CEO to Join Panel at 18th Annual Biotech in Europe Forum
Press ReleasesPanel to Highlight Advanced Therapeutics for Oncology October 03, 2018 12:00 AM Eastern Daylight Time BASEL, Switzerland--(BUSINESS WIRE)--Tomorrow, William Hearl, Ph.D., Chief Executive Officer (CEO) of Immunomic Therapeutics, Inc., willRead moreICYMI…Immunomic Therapeutics Presents at the 2018 BIO Investor Forum…Watch webcast here
Featured Past Events Press ReleasesImmunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company presented at the 2018 BIO Investor Forum held in San Francisco, CA on October 17-18. William Hearl, Ph.D., Immunomic’s FounderRead moreImmunomic Therapeutics, Inc. Founder and CEO Bill Hearl Joins Rich Bendis for BioTalk Podcast
Featured Highlights PressImmunomic Therapeutics, Inc. Founder and CEO Bill Hearl Joins Rich Bendis for BioTalk Click to hear the interview: Bill Hearl Q&A Dr. Bill Hearl is the Founder and Chief Executive OfficerRead moreQ&A with Dr. Heiland, Sr. VP R&D
Blog Featured Highlights PressOur very own Dr. Heiland has been featured on BioBuzz. Click below to read the full Q&A Interview, as Dr. Heiland discusses our technology platform name change to UNITE andRead more